Cargando…
Pyrrolo[2,1-f][1,2,4]triazine: a promising fused heterocycle to target kinases in cancer therapy
Cancer is the second leading cause of death worldwide responsible for about 10 million deaths per year. To date several approaches have been developed to treat this deadly disease including surgery, chemotherapy, radiation therapy, hormonal therapy, targeted therapy, and synthetic lethality. The tar...
Autores principales: | Singh, Sarbjit, Utreja, Divya, Kumar, Vimal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590428/ https://www.ncbi.nlm.nih.gov/pubmed/34803342 http://dx.doi.org/10.1007/s00044-021-02819-1 |
Ejemplares similares
-
Facile and Scalable Methodology for the Pyrrolo[2,1-f][1,2,4]triazine of Remdesivir
por: Roy, Sarabindu, et al.
Publicado: (2022) -
Synthetic strategies for pyrrolo[2,1-f][1,2,4]triazine: the parent moiety of antiviral drug remdesivir
por: Rai, Gaurav S., et al.
Publicado: (2021) -
Discovery of pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of adaptor protein 2-associated kinase 1 for the treatment of pain
por: Dzierba, Carolyn D., et al.
Publicado: (2023) -
Regio- and Diastereoselective 1,3-Dipolar Cycloadditions
of 1,2,4-Triazin-1-ium Ylides: a Straightforward Synthetic Route to
Polysubstituted Pyrrolo[2,1-f][1,2,4]triazines
por: Galeta, Juraj, et al.
Publicado: (2022) -
Exploring Pyrrolo-Fused Heterocycles as Promising Anticancer Agents: An Integrated Synthetic, Biological, and Computational Approach
por: Amărandi, Roxana-Maria, et al.
Publicado: (2023)